Keapstone Therapeutics
Keapstone Therapeutics is a single asset biotech developing drugs that target the Nrf2 signalling pathway (KEAP1 inhibitors) for two devastating conditions – Parkinson’s and Motor Neuron Disease (MND)...load more
Keapstone Therapeutics's Basic Information
Keapstone Therapeutics's Competitors
Frequently Asked Questions Regarding Keapstone Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts